Life expectancy benefits of cancer screening in the end-stage renal disease population (Q33838735)

29 July 2017

title

Life expectancy benefits of cancer screening in the end-stage renal disease population (English)

1 reference

29 July 2017

0 references

1 reference

LeBrun CJ

1

1 reference

29 July 2017

Diehl LF

2

1 reference

29 July 2017

Abbott KC

3

1 reference

29 July 2017

Welch PG

4

1 reference

29 July 2017

Yuan CM

5

1 reference

29 July 2017

publication date

1 February 2000

1 reference

American Journal of Kidney Diseases

29 July 2017

published in

1 reference

29 July 2017

volume

35

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

237-243

1 reference

Increased incidence of malignancy in chronic renal failure

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970332-5

7 January 2021

Increased incidence of malignancy during chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970332-5

7 January 2021

Cancer in patients receiving dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970332-5

7 January 2021

Neoplasms in dialysis patients: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970332-5

7 January 2021

Incidence and Mortality Pattern of Malignancy and Factors Affecting the Risk of Malignancy in Dialysis Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970332-5

7 January 2021

Cost-effectiveness of Cancer Screening in End-Stage Renal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970332-5

7 January 2021

A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970332-5

7 January 2021

Estimating treatment benefits for the elderly: the effect of competing risks

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970332-5

7 January 2021

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970332-5

7 January 2021

Report of the International Workshop on Screening for Breast Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970332-5

7 January 2021

Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970332-5

7 January 2021

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970332-5

7 January 2021

Randomised controlled trial of faecal-occult-blood screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970332-5

7 January 2021

A review of quality of life in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970332-5

7 January 2021

10.1016/S0272-6386(00)70332-5

Identifiers

DOI

1 reference

release_6aurztaix5fqlgclgudypgo4au

29 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6aurztaix5fqlgclgudypgo4au

24 November 2022

mapped directly with Wikidata item

1 reference